Nancy Briefs Joins Mitre Medical Corp. Board of Directors Morgan Hill, CA. Mitre Medical is pleased to announce the addition of Nancy Briefs to our Board of Directors. Ms. Briefs is a strategic business leader in life sciences, with extensive experience creating value, driving strategy, and launching products. In her career, Ms. Briefs has raised over … Read more
PARIS, May 22, 2019 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced strategic clinical and regulatory milestones for its Edwards PASCAL transcatheter valve repair system. Today at the EuroPCR annual course in Paris, new 6-month data from the CLASP study of the PASCAL … Read more
Read Full Article here: https://www.medtechdive.com/news/abbott-gains-expanded-indication-for-mitraclip-valve-repair-device/550580/
Silicon Valley, December, 2018 – Proportionate and Disproportionate Functional Mitral Regurgitation A New Conceptual Framework That Reconciles the Results of the MITRA-FR and COAPT Trials Paul A. Grayburn, Anna Sannino and Milton Packer Read full article here: http://imaging.onlinejacc.org/content/early/2018/11/28/j.jcmg.2018.11.006
Silicon Valley, September, 2018 – COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF. Physicians responded with shock and excitement to findings, but struggled to reconcile the results with the MITRA-FR trial. Read article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1806640 Gregg W. Stone, M.D. et al. for the COAPT Investigators*
Silicon Valley, September 7, 2018 –Mitre Medical has been invited to introduce the Mitral Touch epicardial annuloplasty system that enables a beating heart option for the surgical treatment of mitral regurgitation during the 9 September Innovator’s Day poster session, as part of the PCR London Valves meeting, to be held 9–11 September in London, UK. … Read more
Silicon Valley, August, 2018 – Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation Jean-François Obadia, M.D. et al., for the MITRA-FR Investigators* Read full article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1805374
Speyer/Silicon Valley, 05/08/2018 – AngioConsult announces the strengthening of the cooperation with Mitre Medical Corp. with the addition of Andrew Kim to the team. Andrew is the second representative of AngioConsult supporting the medical device company, which is based in Silicon Valley, California. Benjamin Rieck, Sr Managing Partner of the healthcare consultancy with headquarters in … Read more
Silicon Valley, April 17, 2018 – Mitre Medical Corp. announces successful recruitment of experienced cardiac surgery business executive Maria Sainz as a Strategic Advisor. Ms. Sainz brings more than two decades of medical device industry experience most recently as President and CEO of CardioKinetix. Notable among prior senior leadership roles, she served as President of … Read more
Silicon Valley, 03/28/2018 – Mitre Medical Corp. announces completion of the feasibility phase of the Study of the Mitral Touch System for the Reduction of Mitral Valve Regurgitation (the EnraptMR Trial). Treatment with the Mitral Touch implant has demonstrated safety and technical success including durability of MR reduction at 30 days. “Validation of durable MR reduction on … Read more